FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

BLUTT MITCHELL J MD		 2. Issuer Name and Ticker or Trading Symbol

Consonance-HFW Acquisition Corp. [ CHFW ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

C/O CONSONANCE-HFW ACQUISITION CORP., 1 PALMER SQUARE, SUITE 305		 3. Date of Earliest Transaction (MM/DD/YYYY)

11/23/2020
(Street)

PRINCETON, NJ 08540
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

11/25/2020 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class B Ordinary Shares (6)9/4/2020  A  3593750 A$0.007 3593750 I See Footnote (2)
Class B Ordinary Shares (6)10/8/2020  D  718750 D$0.00 (7)2875000 I See Footnote (2)
Class B Ordinary Shares (6)11/10/2020  D  575000 D$0.00 (7)2300000 I See Footnote (2)
Class B Ordinary Shares (6)11/18/2020  S  30000 D$0.0109 2270000 I See Footnote (2)
Class B Ordinary Shares (6)11/18/2020  S  30000 D$0.0109 2240000 I See Footnote (2)
Class B Ordinary Shares (6)11/18/2020  S  30000 D$0.0109 2210000 I See Footnote (2)
Class A Ordinary Shares 11/23/2020  A(6)  410000 A (1)410000 I See Footnote (2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrant (1)(5)$11.50 11/23/2020  A (6)  136667     (3) (4)Class A Ordinary Shares 136667  (1)136667 I See Footnote (2)
Explanation of Responses:
(1) Includes securities underlying the 410,000 private placement units of the Issuer purchased by Consonance Life Sciences, LLC (the "Sponsor") for $10.00 per private placement unit. The private placement units were purchased in a private placement that closed simultaneously with the closing of the Issuer's initial public offering. Each unit consists of one Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one Class A ordinary share at $11.50 per share.
(2) The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion over the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
(3) The warrants will become exercisable on the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering.
(4) The warrants will expire five years after the completion of the Issuer's initial business combination.
(5) Includes 136,667 warrants underlying the units referred to in footnote 1.
(6) This Form 4 amendment is being filed to correct the original Form 4 filed on November 25, 2020. The original Form 4 had the incorrect transaction code, and did not include reporting of all of the required transactions.
(7) The Sponsor contributed these shares back to the Issuer for no consideration.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
BLUTT MITCHELL J MD
C/O CONSONANCE-HFW ACQUISITION CORP.
1 PALMER SQUARE, SUITE 305
PRINCETON, NJ 08540		X
Signatures
/s/Kevin Livingston, Attorney-in-Fact5/19/2021
**Signature of Reporting PersonDate
Consonance HFW Acquisition (AMEX:CHFW)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Consonance HFW Acquisition.
Consonance HFW Acquisition (AMEX:CHFW)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Consonance HFW Acquisition.